Gastroenterology
Volume 131, Issue 1 , Pages 85-96, July 2006

Does Cross-Reactivity Between Mycobacterium avium paratuberculosis and Human Intestinal Antigens Characterize Crohn’s Disease?

  • Dimitrios Polymeros

      Affiliations

    • University College London, London, United Kindgom
  • ,
  • Dimitrios P. Bogdanos

      Affiliations

    • Institute of Liver Studies, King’s College Hospital, Division of Gene and Cell Based Therapy, GKT Medical School, Denmark HillLondon, United Kingdom
  • ,
  • Richard Day

      Affiliations

    • Burdett Institute of Gastrointestinal Nursing, King’s College London & St Mark’s Hospital, London, England
  • ,
  • Dimitryi Arioli

      Affiliations

    • Institute of Liver Studies, King’s College Hospital, Division of Gene and Cell Based Therapy, GKT Medical School, Denmark HillLondon, United Kingdom
  • ,
  • Diego Vergani

      Affiliations

    • Institute of Liver Studies, King’s College Hospital, Division of Gene and Cell Based Therapy, GKT Medical School, Denmark HillLondon, United Kingdom
  • ,
  • Alastair Forbes

      Affiliations

    • University College London, London, United Kindgom
    • Corresponding Author InformationAddress requests for reprints to: Alastair Forbes, MD, Department of Gastroenterology, University College Hospital, 235 Euston Road, London NW1 2BU, England.fax: (44) 20-8342-8308.

Received 24 February 2006; accepted 30 March 2006.

Background & Aims: Most Crohn’s disease (CD) patients show seroreactivity against Mycobacterium avium paratuberculosis (MAP), suggesting a pathogenic role for this organism. Our aim was to seek amino acid similarities between MAP and intestinal proteins that, through molecular mimicry, could serve as targets for cross-reactive immunity in CD.

Methods: Fifty-three peptides comprising 23 sets of MAP/human intestinal peptidyl mimics chosen for maximal homology were constructed and tested for immunologic cross-reactivity by enzyme-linked immunosorbent assay in 50 patients with CD, 50 with ulcerative colitis, and 38 healthy controls.

Results: Antibody reactivity was present in only 7 of 23 peptide sets. MAP/self-reactivity in at least 1 of the 7 reactive sets was present in 21 (42%) CD patients but was virtually absent in the controls. Significant double-reactivity was found against MAP glycosyl transferase d (gsd)230–244/human gastrointestinal glutathione peroxidase (GPg)111–125 homologues in 15 of 50 (30%) CD patients; MAP alkylohydroperoxidase C (ahpC)20–34/human tumor overexpressed protein (TOG)637–651 double-reactivity was present in 10 (20%) CD patients, but in none of the controls. Inhibition studies confirmed that simultaneous reactivity to mimics was caused by cross-reactivity. Three-dimensional modeling predicts GPg111–125 will be exposed in a solvent-accessible surface region of the protein compatible with antibody recognition. Antibody affinity was greater for the MAP mimics than for the self-sequences, suggesting that reactivity to the mycobacterial sequences precedes that against self-sequences.

Conclusions: We describe MAP/self-mimics as targets of cross-reactive antibody responses characterizing patients with CD. Our findings indicate gastrointestinal glutathione peroxidase as a novel autoantigen in CD.

Abbreviations used in this paper:  ahpC, alkylohydroperoxidase C , ELISA, enzyme-linked immunosorbent assay , GPg, gastrointestinal glutathione peroxidase , gsd, glycosyl transferase d , MAP, Mycobacterium avium paratuberculosis , TOG, tumor overexpressed protein

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 D.P. and D.P.B. contributed equally to this article.Supported by St. Mark’s Hospital Foundation (D.P.); and by the Children’s Liver Disease Foundation, Birmingham, United Kingdom (D.P.B.).

PII: S0016-5085(06)00763-3

doi:10.1053/j.gastro.2006.04.021

Refers to article:

  • In Search of Desire: Mimicry, MAP, and Crohn’s Disease

    Jonathan Braun
    Gastroenterology July 2006 (Vol. 131, Issue 1, Pages 312-314)

Gastroenterology
Volume 131, Issue 1 , Pages 85-96, July 2006